| 产品详情 |
| Edit |   |
|---|
| Product Name | TCF-3/E2A Blocking Peptide |
|---|
| Description | The TCF-3/E2A Blocking Peptide has been validated for the following applications: Antibody Competition. |
|---|
| Size | 0.05 mg |
|---|
| Concentration | 0.2 mg/ml |
|---|
| Applications | Antibody Competition |
|---|
| Other Names | BHLHB21, bHLHb21TCF-3, Class B basic helix-loop-helix protein 21, E2A immunoglobulin enhancer-binding factor E12/E47, E2AKappa-E2-binding factor, Immunoglobulin enhancer-binding factor E12/E47, Immunoglobulin transcription factor 1, ITF1Transcription factor ITF-1, MGC129647, MGC129648, Transcription factor 3, transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47), transcription factor E2-alpha, VDIR, VDR interacting repressor |
|---|
| Gene, Accession, CAS # | TCF3, Gene ID: 6929 |
|---|
| Catalog # | NBP1-77119PEP |
|---|
| Price | |
|---|
| Order / More Info | TCF-3/E2A Blocking Peptide from NOVUS BIOLOGICALS, LLC |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|